In the NCT group, multivariate survival analysis displayed that CD4+GzmBCT+ was an independent protective factor for OS and DFS in pMMR CRC patients [hazard ratio (HR), 0.218, and 0.180; p = 0.021, and 0.009, respectively, Cox regression; n = 38]. This evidence concerns the gene CD4 and colorectal carcinoma.